My WebLink
|
Help
|
About
|
Sign Out
REDWOOD TOXICOLOGY LABORATORY, INC. - 2ND AMENDMENT (#2023180)
City of Pleasanton
>
CITY CLERK
>
CONTRACTS
>
R
>
REDWOOD TOXICOLOGY LABORATORY, INC. - 2ND AMENDMENT (#2023180)
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/15/2025 1:01:16 PM
Creation date
12/15/2025 12:59:34 PM
Metadata
Fields
Template:
CONTRACTS
Description Type
Professional Services
Contract Type
Amendment
NAME
REDWOOD TOXICOLOGY LABORATORY, INC. (SECOND AMENDMENT)
Contract Record Series
704-05
Munis Contract #
2023180
Contract Expiration
3/31/2026
NOTES
TOXICOLOGY ANALYSIS AND REPORT SERVICES
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
20
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Second Amendment Page 1 <br />SECOND AMENDMENT TO AGREEMENT <br /> <br /> <br />This Second Amendment to Agreement ("Second Amendment") is entered into this 25th day of <br />August 2025 by the City of Pleasanton ("City") and Redwood Toxicology Laboratory, Inc. <br />(RTL) (Consultant). <br /> <br />Whereas, on August 25, 2022, the City and Consultant entered into a Professional <br />Services Agreement for toxicology analysis and report services, as amended by the First <br />Amendment dated August 25, 2024 (collectively the "Agreement"); and <br /> <br />Whereas, the City desires that the Consultant continue providing professional toxicology <br />services; and <br /> <br />Whereas, the parties desire to amend the Agreement. <br /> <br />Now, therefore, in exchange for valuable consideration, the receipt of which is hereby <br />acknowledged, the parties agree as follows: <br /> <br />1. Section 3 of the Agreement, “Terms,” is amended to read: This agreement shall <br />expire on March 31, 2026, unless terminated earlier in accordance with Section 9 <br />below. <br /> <br />2. The first paragraph of Section 4 of the Agreement, “Compensation” is amended to <br />read: City shall pay Consultant for services rendered pursuant to this Agreement as <br />described more particularly in Exhibit B. The payments shall be made on a monthly <br />basis upon receipt and approval of Consultant’s invoice. Total compensation for <br />services and reimbursement for costs for the period between August 25, 2022 and <br />August 25, 2025 shall not exceed $40,000. Total compensation for the period <br />between August 26, 2025 and March 31, 2026 shall not exceed $12,000 Consultant <br />may update its rates no more frequently than annually with at least sixty days written <br />notice to the City. Upon receiving notice of a price increase, the parties shall amend <br />this Agreement by updating and attaching a revised Exhibit B. <br /> <br />3. Section 4 of the Agreement, “Compensation,” is amended to incorporate the attached <br />Exhibit B – Toxicology Fee Schedule dated August 26, 2025, in place of Exhibit B of <br />the Agreement. <br /> <br />4. Section 8 of the Agreement, “Termination for Convenience of City” is amended to <br />read: Either Party may terminate this Agreement at any time by mailing a notice in <br />writing to the other party. The Agreement shall then be deemed terminated, and no <br />further work shall be performed by Consultant. If the Agreement is so terminated, the <br />Consultant shall be paid for that percentage of the work actually completed at the <br />time the notice of termination is received. <br /> <br />5. This amendment may be executed in multiple counterparts, each of which shall be an <br />original and all of which together shall constitute one agreement. Counterparts may <br />be delivered via facsimile, electronic mail (including pdf or any electronic signature <br />complying with U.S. federal E-Sign Act of 2000 (15 U.S. Code §7001 et seq.), <br />California Uniform Electronic Transactions Act (Cal. Civil Code §1633.1 et seq.), or <br />other applicable law) or other transmission method, and any counterpart so delivered <br />Docusign Envelope ID: C09E0570-8A84-409A-AB66-0BA6C0CA9C42Docusign Envelope ID: 9FD2585C-32C8-4D74-9FB2-74BAEC93C6B8
The URL can be used to link to this page
Your browser does not support the video tag.